The largest database of trusted experimental protocols

4 protocols using bapta

1

Calcium Imaging in Ischemia-Reperfusion

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were seeded in a 35 mm dish and performed OGD/R and drug treatment. After 24 h of reoxygenation, replaced with fluorescent dye solution (DMEM: F-127: Fura-2 AM = 500: 1: 1) for 20 min, and then washed 3 times with artificial extracellular solution. Fluorescence of Fura-2 AM was measured at 340 nm (F340) and 380 nm (F380) under alternating excitation per second using an Olympus Digital Calcium Imaging System (IX73, DG-4PLUS/OF30, Japan). Images were acquired for 300s to obtain baseline Ca2+ levels with extracellular Ca2+ (1 mM). The extracellular solution was then replaced by adding BAPTA (1 mM, MedChemExpress, USA) or CaCl2 (Ca2+, 2 mM) and the ratio (F340/F380) was recorded. The △ratio (F340/F380) was calculated to indicate the change of [Ca2+]i levels before and after treatment with BAPTA or high calcium solution. The experiments were performed at least three independent experiments.
+ Open protocol
+ Expand
2

Pharmacological Modulators of Cellular Mechanobiology

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pharmacological and small‐molecule inhibitors and agonists used were the following: 7rh (2.5 µm; Sigma) for DDR1 inhibition, rat anti‐human CD29 (1:100; BD Bioscience) to block integrin β1, blebbistatin (1 µm; Enzo Life Sciences) for myosin II inhibition, GM6001 (10 µm; Calbiochem) as broad‐spectrum MMP inhibitor, L‐mimosine (400 µm; Santa Cruz Biotechnology) to arrest the cell cycle at G1, S‐trityl‐L‐cysteine (STLC; 20 µm; Santa Cruz Biotechnology) to arrest at mitosis, ionomycin (10 µm; MedChemExpress) to increase cell membrane permeability to calcium, gadolinium chloride (10 µm; MedChemExpress) to inhibit mechanosensitive calcium channels, BAPTA (10 µm; MedChemExpress) to chelate extracellular calcium, BAPTA‐AM (10 µm; MedChemExpress) to chelate intracellular calcium, arachidonic acid (70 µm; MedChemExpress) to mimic signaling downstream of nuclear mechanosensing, AACOCF3 (28 µm; Tocris) to inhibit signaling downstream of nuclear mechanosensing, 2‐aminoethoxydiphenylborane (20 µm; MedChemExpress) as IP3 receptor agonist, Xestospongin c (10 µm; Tocris) as IP3 receptor agonist, GSMT×4 (10 µm; MedChemExpress) as Piezo 1 inhibitor, Yoda1 (6 µm; MedChemExpress) as Piezo 1 agonist, GSK205 (10 µm; MedChemExpress) as TRPV4 inhibitor, and GSK1016790A (50 µm; MedChemExpress) as TRPV4 agonist.
+ Open protocol
+ Expand
3

Antibody and Reagent Acquisition Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-HA, FLAG, and β-actin mouse monoclonal antibodies were purchased from Proteintech (USA, Chicago), and an anti-S100A9 rabbit polyclonal antibody was purchased from Abcam (Cambridge, UK). BAPTA, a specific intracellular Ca2+ chelating agent, was purchased from MedChemExpress (New Jersey, USA). PMSF was purchased from Solarbio (Beijing, China). The anti-PRRSV N protein mAb was prepared in our lab.
+ Open protocol
+ Expand
4

Comprehensive DNA Damage Response Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The NO donor drug JS-K was obtained from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA) and the Calcium ion chelating agent BAPTA was purchased from MedChemExpress (MCE, NJ, USA). JS-K and BAPTA were dissolved in dimethyl sulfoxide (DMSO) to concentrations of 5 mM and 20 mM respectively and stored in the refrigerator at -80 ℃. Antibodies against Phosphorylated histone H2AX (γH2AX), RAD51, PCNA, Phospho-ATM (p-ATM), Phospho-ATR (p-ATR), Phospho-Chk1 (p-Chk1), Phospho-Chk2 (p-Chk2), Phospho-Cdc2 (p-Cdc2), Cyclin B1, Phospho-CAMKKβ (p-CAMKKβ), Phospho-AMPKα (p-AMPKα), mTOR, Phospho-mTOR (p-mTOR), LC3B, Beclin 1, P62, GAPDH were purchased from Cell Signaling Technology, Inc. (Danvers, MA, USA). Antibodies against AMPKα were purchased from Cohesion Biotechnology Co., Ltd (Beijing, China). The Horseradish peroxidase conjugated IgG secondary antibodies were obtained from Shanghai Beyotime Biotechnology Co., Ltd.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!